About: covid:arg/c4cbd1688696aa74b7f732468c0333088d5a5ce4/2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:arg/c4cbd1688696aa74b7f732468c0333088d5a5ce4/2 Goto Sponge NotDistinct Permalink

An Entity of Type : amo:Claim, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	sioca:Idea aif:I-node aif:KnowledgePosition_Statement claim
wasQuotedFrom	Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma
sioca:supports	covid:arg/c4cbd1688696aa74b7f732468c0333088d5a5ce4/3
aif:claimText	Prolonged administration of enzalutamide decreased apoptosis , increased tumor burden and resulted in the clonal expansion of tumor cells expressing high levels of p53 protein , suggestive of acquired Trp53 mutations .
proves	covid:arg/c4cbd1688696aa74b7f732468c0333088d5a5ce4/3
is hasSource of	nodeID://b56364168 nodeID://b56470368 nodeID://b56624816 nodeID://b56716192 nodeID://b56978048 nodeID://b57034640 nodeID://b57080168 nodeID://b57093740 nodeID://b57157552 nodeID://b57266396 nodeID://b57298480 nodeID://b57366960 nodeID://b57370764 nodeID://b57441296 nodeID://b57564560 nodeID://b57564724 nodeID://b57572136 nodeID://b57659568 nodeID://b57680484 nodeID://b57704244 nodeID://b57757984 nodeID://b57758136 nodeID://b58055288 nodeID://b58081284 nodeID://b58117940 nodeID://b58164408
is has claim of	covid:arg/c4cbd1688696aa74b7f732468c0333088d5a5ce4

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software